Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;52(6):516-520.
doi: 10.1007/s10038-007-0147-0. Epub 2007 May 4.

The 894G>T variant in the endothelial nitric oxide synthase gene and spina bifida risk

Ivon J M van der Linden  1 , Sandra G Heil  1 , Martin den Heijer  2   3 , Henk J Blom  4   5
Affiliations

The 894G>T variant in the endothelial nitric oxide synthase gene and spina bifida risk

Ivon J M van der Linden et al. J Hum Genet. 2007.

Abstract

The 894G>T single nucleotide polymorphism (SNP) in the endothelial NOS (NOS3) gene, has recently been associated with embryonic spina bifida risk. In this study, a possible association between the NOS3 894G>T SNP and spina bifida risk in both mothers and children in a Dutch population was examined using both a case-control design and a transmission disequilibrium test (TDT). Possible interactions between the NOS3 894G>T SNP and the MTHFR 677C>T SNP, elevated plasma homocysteine, and decreased plasma folate concentrations were also studied. The NOS3 894TT genotype did not increase spina bifida risk in mothers or children (OR 1.50, 95%CI 0.71-3.19 and OR 1.78, 95%CI 0.75-4.25, respectively). The TDT demonstrated no preferential transmission of the NOS3 894T allele (Chi2=0.06, P=0.81). In combination with the MTHFR 677TT genotype or elevated plasma homocysteine concentrations, the NOS3 894GT/TT genotype increased maternal spina bifida risk (OR 4.52, 95%CI 1.55-13.22 and OR 3.38, 95%CI 1.46-7.84, respectively). In our study population, the NOS3 894GT/TT genotype might be a risk factor for having a spina bifida affected child in mothers who already have an impaired homocysteine metabolism.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1161/01.ATV.0000071348.70527.F4', 'is_inner': False, 'url': 'https://doi.org/10.1161/01.atv.0000071348.70527.f4'}, {'type': 'PubMed', 'value': '12689917', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12689917/'}]}
    2. Brown KS, Kluijtmans LA, Young IS, Woodside J, Yarnell JW, McMaster D, Murray L, Evans AE, Boreham CA, McNulty H, Strain JJ, Mitchell LE, Whitehead AS (2003) Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 23:1014–1020 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/bdra.20002', 'is_inner': False, 'url': 'https://doi.org/10.1002/bdra.20002'}, {'type': 'PubMed', 'value': '15039923', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15039923/'}]}
    2. Brown KS, Cook M, Hoess K, Whitehead AS, Mitchell LE (2004) Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res Part A Clin Mol Teratol 70:101–106 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1074/jbc.M104043200', 'is_inner': False, 'url': 'https://doi.org/10.1074/jbc.m104043200'}, {'type': 'PubMed', 'value': '11371572', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11371572/'}]}
    2. Danishpajooh IO, Gudi T, Chen Y, Kharitonov VG, Sharma VS, Boss GR (2001) Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem 276:27296–27303 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(95)90008-X', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(95)90008-x'}, {'type': 'PubMed', 'value': '7707810', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7707810/'}]}
    2. den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, Bos GM (1995) Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 345:882–885 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1074/jbc.M103647200', 'is_inner': False, 'url': 'https://doi.org/10.1074/jbc.m103647200'}, {'type': 'PubMed', 'value': '11331296', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11331296/'}]}
    2. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC (2001) Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)->Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276:26674–26679 - PubMed

Publication types

Substances

LinkOut - more resources